C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/437 (2006.01) C07D 209/00 (2006.01) C07D 221/00 (2006.01)
Patent
CA 2527773
Novel cycloalkanepyrrolopyridine derivatives are antagonists of prostaglandins, and as such are useful for the treatment of prostaglandin mediated diseases.
La présente invention concerne de nouveaux dérivés de cycloalkanepyrrolopyridine qui sont des antagonistes de prostaglandines et qui, de ce fait, conviennent pour le traitement de maladies induites par la prostaglandine.
Lachance Nicolas
Sturino Claudio
Merck Frosst Canada Ltd.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Cycloalkanepyrrolopyridines as dp receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cycloalkanepyrrolopyridines as dp receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cycloalkanepyrrolopyridines as dp receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1813812